Aside from familial mutations in NLRP1 that predispose humans to skin cancer, common polymorphisms at the NLRP1 locus are associated with resistance to glucocorticoid treatment in pediatric IBD, and several autoimmune diseases such as vitiligo, celiac disease and psoriasis15,19–22. This evidence concerns the gene NLRP1 and inflammatory bowel disease.